ACTA1 Gene Nemaline Myopathy Type 3 Genetic Test
At DNA Labs UAE, we offer the ACTA1 Gene Nemaline Myopathy Type 3 Genetic Test. This test is designed to identify potential mutations or variations in the ACTA1 gene associated with nemaline myopathy type 3, a rare genetic disorder characterized by muscle weakness and low muscle tone (hypotonia).
Test Components and Price
- Components: ACTA1 Gene Nemaline Myopathy Type 3 Genetic Test
- Price: 4400.0 AED
Sample Condition and Report Delivery
- Sample Condition: Blood
- Report Delivery: 3 to 4 Weeks
Method and Test Type
- Method: NGS Technology (Next-Generation Sequencing)
- Test Type: Neurological Disorders
Doctor and Test Department
- Doctor: Neurologist
- Test Department: Genetics
Pre-Test Information
Prior to undergoing the ACTA1 Gene Nemaline Myopathy Type 3 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by ACTA1 Gene Nemaline Myopathy Type 3.
About the Test
The ACTA1 gene is associated with nemaline myopathy type 3. Next-generation sequencing (NGS) technology is utilized to analyze multiple genes simultaneously and identify genetic variations or mutations. The NGS genetic test for nemaline myopathy type 3 involves sequencing the ACTA1 gene to detect potential mutations or variations that may be causing the disorder. This test aids in confirming a diagnosis and understanding the underlying genetic cause of the condition.
Genetic testing is beneficial for individuals displaying symptoms suggestive of nemaline myopathy type 3, as well as their family members who may be at risk of carrying the same genetic mutation. It provides crucial information for healthcare providers to develop appropriate treatment plans and genetic counseling for affected individuals and their families.
Test Name | ACTA1 Gene Nemaline myopathy type 3 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for ACTA1 Gene Nemaline myopathy type 3 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ACTA1 Gene Nemaline myopathy type 3 |
Test Details |
The ACTA1 gene is associated with nemaline myopathy type 3, which is a rare genetic disorder characterized by muscle weakness and low muscle tone (hypotonia). NGS stands for next-generation sequencing, which is a technique used to analyze multiple genes simultaneously to identify genetic variations or mutations. An NGS genetic test for nemaline myopathy type 3 would involve sequencing the ACTA1 gene to identify any potential mutations or variations that may be causing the disorder. This can help in confirming a diagnosis and understanding the underlying genetic cause of the condition. Genetic testing can be useful for individuals with symptoms suggestive of nemaline myopathy type 3, as well as for their family members who may be at risk of carrying the same genetic mutation. It can provide important information for healthcare providers to develop appropriate treatment plans and genetic counseling for affected individuals and their families. |